Cloning and tissue distribution of a novel human cytochrome p450 of the CYP3A subfamily, CYP3A43.
about
Intergenic mRNA molecules resulting from trans-splicingSequence diversity and haplotype structure at the human CYP3A clusterOPRM1 and CYP2B6 gene variants as risk factors in methadone-related deathsDrug metabolism in human brain: high levels of cytochrome P4503A43 in brain and metabolism of anti-anxiety drug alprazolam to its active metaboliteGenetic variability in CYP3A5 and its possible consequences.The frameshift polymorphism CYP3A43_74_delA is associated with poor differentiation of breast tumors.Effects of maternal acrolein exposure during pregnancy on testicular testosterone production in fetal rats.The cyclophosphamide metabolite, acrolein, induces cytoskeletal changes and oxidative stress in Sertoli cells.Integrated transcriptional and proteomic analysis with in vitro biochemical assay reveal the important role of CYP3A46 in T-2 toxin hydroxylation in porcine primary hepatocytesThe revised human liver cytochrome P450 "Pie": absolute protein quantification of CYP4F and CYP3A enzymes using targeted quantitative proteomics.Human drug metabolism and the cytochromes P450: application and relevance of in vitro models.Metabolic pathways of inhaled glucocorticoids by the CYP3A enzymes.Expression and regulation of xenobiotic-metabolizing cytochrome P450 (CYP) enzymes in human lung.Genetic variation in CYP3A43 explains racial difference in olanzapine clearance.Decision tree-based modeling of androgen pathway genes and prostate cancer riskPharmacogenetics of the major polymorphic metabolizing enzymes.Orphans in the human cytochrome P450 superfamily: approaches to discovering functions and relevance in pharmacology.Pharmacogenomics of drugs affecting the cardiovascular system.CYP3A5 phenotype-genotype correlations in a British population.Diltiazem inhibits human intestinal cytochrome P450 3A (CYP3A) activity in vivo without altering the expression of intestinal mRNA or protein.Differences in drug pharmacokinetics between East Asians and Caucasians and the role of genetic polymorphisms.Clinical implications of CYP3A polymorphisms.Characterization of orphan human cytochromes P450.PhRMA white paper on ADME pharmacogenomics.A double transgenic mouse model expressing human pregnane X receptor and cytochrome P450 3A4Pharmacogenomics of CYP3A: considerations for HIV treatment.The Making of a CYP3A Biomarker Panel for Guiding Drug Therapy.Ambient tonicity and intestinal cytochrome CYP3A.Production of human phase 1 and 2 metabolites by whole-cell biotransformation with recombinant microbes.Developmental changes in the expression and function of cytochrome P450 3A isoforms: evidence from in vitro and in vivo investigations.Pharmacogenetics of olanzapine metabolism.Genetic variation in CYP3A43 is associated with response to antipsychotic medication.Biotransformation of xenobiotics in the human colon and rectum and its association with colorectal cancer.Pharmacogenomics and pharmacogenetics for the intensive care unit: a narrative review.The mechanisms of cyclophosphamide-induced testicular toxicity and the protective agents.Molecular mechanisms of polymorphic CYP3A7 expression in adult human liver and intestine.Interindividual and intraindividual variability of the urinary 6beta-Hydroxycortisol/Cortisol ratio in Chinese subjects: implications of its use for evaluating CYP3A activity.Impact of CYP3A5 genotype on tacrolimus versus midazolam clearance in renal transplant recipients: new insights in CYP3A5-mediated drug metabolism.A novel polymorphic cytochrome P450 formed by splicing of CYP3A7 and the pseudogene CYP3AP1.Enzymatic characteristics of CYP3A5 and CYP3A4: a comparison of in vitro kinetic and drug-drug interaction patterns.
P2860
Q28118695-A3C36B54-6A48-4FCF-AA71-D62C9235E392Q28284189-5669F70E-1AD7-4568-8AC3-60350903FD53Q28289166-F18328BF-4C3D-47F8-AB4C-E01A6EA76B05Q28472957-47C3332C-3495-4A5F-8464-DA8FA9170500Q30341330-F6A9C7E2-686B-4964-98A5-51A276D5B719Q33660484-6E5AF282-EE2D-43DA-894A-576C010358D2Q33827962-4C7BA98E-6797-46D4-891C-3A8E01895F2BQ33892820-15CB5A75-943E-4B2B-BA43-DCCCAE37F843Q33936029-E1838B40-2D6F-4308-BC1B-08BFD60DA65BQ33942983-0F4ECD9C-DEDE-426E-8805-51D989A8A147Q34430456-4091A401-1DD2-4BB3-8196-6F6571075430Q34660924-2EDA9FAF-52EA-420C-B4AF-3D7B8E8E6035Q34975657-ED4C1763-008C-4D88-B179-6DF1F71CBF77Q35000771-9F91294B-C597-4374-ADD1-BE646C66CBB3Q35036697-94046911-9FF8-4FA3-9D9C-76C91F42B34BQ35067187-464D61E9-6B35-405F-9A55-8FA1E39DBCA2Q35122778-CD0C9D35-F6EF-4A1A-AF74-3BCA6BA65470Q35127795-A20E87EE-05A7-48CD-A999-77151E187052Q35825323-F16D19AB-EAB4-4B31-8D27-963EA9F4C569Q35826861-A0F36021-D423-4962-8A3F-560110EEEFB2Q35876954-9C4C73F7-C838-421B-8586-A4BD8C3F5138Q36546247-D1E8A2B4-5FAF-481F-8876-D0803783B2B0Q36929625-DB8D415C-C838-432E-86B5-90A91F37DCE5Q37182212-1DD9C7EC-B505-46D1-B37C-45B13FE4498FQ37183874-553BB64E-7258-475E-9EE8-8D699E322F20Q37419542-F6BB9155-5635-433B-B377-7D42DF191FBBQ37513374-F452B34E-6F22-4B1A-9707-E0A518CD4E67Q37725997-DD65BDA5-1F47-4DB0-8C19-6EEA402DC6F7Q37810229-D1066368-2A5D-4611-9E7E-C6E3713B1981Q38086777-7E2ADB1B-4028-4043-BA6E-C3544FEE0C38Q38127716-4BB29015-B1E5-4415-A30D-AFDEAAAD0FC1Q38242595-7CB88392-4393-4A55-88DD-155323995E92Q38357424-E1B1C4C6-5A64-40B5-AB1C-0E957982BB77Q38983589-F43C8C50-810B-4F1B-B68C-B17B9228C252Q39055412-E52C284E-54C1-4F9F-9294-3FB7DA8B3C6DQ43952477-CE254D8D-A989-4A91-A837-51DDE6AE2F2DQ45151697-71A69EDF-A8B5-4357-82E5-02CD409C1F4EQ45279289-553A316B-E08D-475D-BBED-A05487576B8FQ46529262-60AB04C5-F6E2-409A-889B-D28FA9716A0EQ48698266-04DB7704-E6C7-4342-8A90-B66F5B587A94
P2860
Cloning and tissue distribution of a novel human cytochrome p450 of the CYP3A subfamily, CYP3A43.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Cloning and tissue distributio ...... the CYP3A subfamily, CYP3A43.
@ast
Cloning and tissue distributio ...... the CYP3A subfamily, CYP3A43.
@en
type
label
Cloning and tissue distributio ...... the CYP3A subfamily, CYP3A43.
@ast
Cloning and tissue distributio ...... the CYP3A subfamily, CYP3A43.
@en
prefLabel
Cloning and tissue distributio ...... the CYP3A subfamily, CYP3A43.
@ast
Cloning and tissue distributio ...... the CYP3A subfamily, CYP3A43.
@en
P2093
P356
P1476
Cloning and tissue distributio ...... the CYP3A subfamily, CYP3A43.
@en
P2093
Andersson TB
Johansson I
Oscarson M
Westlind A
P304
P356
10.1006/BBRC.2001.4505
P407
P577
2001-03-01T00:00:00Z